Designer macrocyclic organo-peptide hybrids inhibit the interaction between p53 and HDM2/X by accommodating a functional α-helix
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Designer macrocyclic organo-peptide hybrids inhibit the interaction between p53 and HDM2/X by accommodating a functional α-helix
Authors
Keywords
-
Journal
CHEMICAL COMMUNICATIONS
Volume 50, Issue 39, Pages 5027-5030
Publisher
Royal Society of Chemistry (RSC)
Online
2014-04-08
DOI
10.1039/c4cc01199f
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain
- (2014) Grzegorz Popowicz et al. CELL CYCLE
- A Perfluoroaryl-Cysteine SNAr Chemistry Approach to Unprotected Peptide Stapling
- (2013) Alexander M. Spokoyny et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Comprehensive Peptidomimetic Libraries Targeting Protein–Protein Interactions
- (2012) Landon R. Whitby et al. ACCOUNTS OF CHEMICAL RESEARCH
- Stapled Peptides with Improved Potency and Specificity That Activate p53
- (2012) Christopher J. Brown et al. ACS Chemical Biology
- Macrocyclization of Organo-Peptide Hybrids through a Dual Bio-orthogonal Ligation: Insights from Structure-Reactivity Studies
- (2012) John R. Frost et al. CHEMBIOCHEM
- Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity
- (2012) Matthew C. Smith et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Development of α-Helical Calpain Probes by Mimicking a Natural Protein–Protein Interaction
- (2012) Hyunil Jo et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Modular Assembly of Macrocyclic Organo-Peptide Hybrids Using Synthetic and Genetically Encoded Precursors
- (2011) Jessica M. Smith et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Achieving cell penetration with distance-matching cysteine cross-linkers: a facile route to cell-permeable peptide dual inhibitors of Mdm2/Mdmx
- (2011) Avinash Muppidi et al. CHEMICAL COMMUNICATIONS
- Diverse organo-peptide macrocyclesvia a fast and catalyst-free oxime/intein-mediated dual ligation
- (2011) Maragani Satyanarayana et al. CHEMICAL COMMUNICATIONS
- Design of Triazole-Stapled BCL9 α-Helical Peptides to Target the β-Catenin/B-Cell CLL/lymphoma 9 (BCL9) Protein–Protein Interaction
- (2011) Steven A. Kawamoto et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
- (2010) Federico Bernal et al. CANCER CELL
- High Specificity in Protein Recognition by Hydrogen-Bond-Surrogate α-Helices: Selective Inhibition of the p53/MDM2 Complex
- (2010) Laura K. Henchey et al. CHEMBIOCHEM
- CuI-Catalyzed AzideâAlkyne Intramoleculari-to-(i+4) Side-Chain-to-Side-Chain Cyclization Promotes the Formation of Helix-Like Secondary Structures
- (2009) Mario Scrima et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Assessment of helical interfaces in protein–protein interactions
- (2009) Andrea L. Jochim et al. Molecular BioSystems
- Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?
- (2009) Mark Wade et al. MOLECULAR CANCER RESEARCH
- Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
- (2009) M. Pazgier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Contemporary strategies for the stabilization of peptides in the α-helical conformation
- (2008) Laura K Henchey et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- The design, structures and therapeutic potential of protein epitope mimetics
- (2008) John A. Robinson et al. DRUG DISCOVERY TODAY
- Turning a Scorpion Toxin into an Antitumor Miniprotein
- (2008) Chong Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started